Author:
Ramzy Sherif,Althobaiti Yusuf S.,Almalki Atiah H.
Reference16 articles.
1. M.R. Chilbert, D. VanDuyn, S. Salah, C.M. Clark, Q. Ma, Combination therapy of ezetimibe and rosuvastatin for dyslipidemia: current insights,Drug Des., Dev. Ther. 16(2022) 2177-2186. DOI: 10.2147/DDDT.S332352.
2. Rosuvastatin and ezetimibe for the treatment of dyslipidemia and hypercholesterolemia;Boutari;Expert Rev. Cardiovasc. Ther.,2021
3. S. Kurbanoğlu, E.S.I.M. Ozgur, K.O.S.E. Cansel, A. Savaşer, Y. Ozkan, U.S.L.U. Bengi, S. Özkan, Stability indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe from pharmaceuticals and biological samples,J. Turk. Chem. Soc., Sect. A7(2020) 865-874. DOI: 10.18596/jotcsa.788227.
4. Simultaneous quantitation of rosuvastatin and ezetimibe in human plasma by LC–MS/MS: pharmacokinetic study of fixed-dose formulation and separate tablets;Bhadoriya;Biomed. Chromatogr.,2018
5. Stability indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe in pharmaceutical formulations;Mukthinuthalapati;Adv. Pharm. Bull.,2014